Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis

  • Veronika Dill
  • , Johanna Kauschinger
  • , Richard T. Hauch
  • , Lars Buschhorn
  • , Timo O. Odinius
  • , Catharina Müller-Thomas
  • , Ritu Mishra
  • , Michele C. Kyncl
  • , Burkhard Schmidt
  • , Peter M. Prodinger
  • , Dirk Hempel
  • , Frauke Bellos
  • , Alexander Höllein
  • , Wolfgang Kern
  • , Torsten Haferlach
  • , Julia Slotta-Huspenina
  • , Florian Bassermann
  • , Christian Peschel
  • , Katharina S. Götze
  • , Irene C. Waizenegger
    • Ulrike Höckendorf, Philipp J. Jost, Stefanie Jilg

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science